THERAPEUTIC AGENTS FOR PANCREATIC CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14878163

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

We achieved the present invention on the basis of the finding that an excellent therapeutic effect against pancreatic cancer can be obtained by administering an IL-6 inhibitor and an antimetabolite to pancreatic cancer patients. We also found that metastatic lesions from human pancreatic cancer can be reduced and ascites can be eliminated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHUGAI SEIYAKU KABUSHIKI KAISHA5-1 UKIMA 5-CHOME KITA-KU TOKYO 115-8543
NATIONAL CANCER CENTER1-1 TSUKIJI 5-CHOME CHUO-KU TOKYO 1040045 ?1040045

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
IKEDA, Masafumi Chiba, JP 18 57
MITSUNAGA, Shuichi Chiba, JP 5 82
OCHIAI, Atsushi Chiba, JP 69 198

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation